Baseline neutrophil-to-eosinophil-ratio and outcome in metastatic clear-cell renal cell carcinoma treated with nivolumab or ipilimumab/nivolumab.
Beulque Y, Kinget L, Roussel E, Mobaraki S, Laenen A, Debruyne PR, Van Herck Y, Baldewijns M, Wozniak A, Garg AD, Zucman-Rossi J, Couchy G, Albersen M, De Wever L, Haaker L, Beuselinck B.
Beulque Y, et al. Among authors: mobaraki s.
Acta Oncol. 2024 Aug 11;63:658-668. doi: 10.2340/1651-226X.2024.40390.
Acta Oncol. 2024.
PMID: 39129249
Free PMC article.